Mammoth Biosciences Signs Agreements with MilliporeSigma and Hamilton Company Targeting Commercialization of High-Throughput CRISPR-based SARS CoV-2 Test
Mammoth Biosciences | November 26, 2020
The company has signed agreements with MilliporeSigma to scale manufacturing and with Hamilton Company to market a turnkey solution to help CLIA laboratories rapidly add testing capacity